期刊文献+

白藜芦醇低聚体对Fos/Jun分子作用的虚拟分析及其镇痛活性 被引量:2

Virtual analysis of interaction of resveratrol oligomer with Fos/Jun and its analgesic activity in mice
原文传递
导出
摘要 目的:探讨白藜芦醇低聚体对疼痛相关基因产物Fos/Jun的分子作用及其镇痛活性。方法:通过Discovery Studio分子对接软件模拟白藜芦醇不同聚合物与Fos/Jun分子的相互作用,并经小鼠脑室注射给药和热板法证实不同聚合物的镇痛作用。结果:白藜芦醇低聚物比单体对Fos/Jun分子的作用更强。单体至三聚体随聚合度增高,其作用加大,但四聚体作用减弱。白藜芦醇及其低聚体均有中枢镇痛作用,其镇痛效果大小与模拟的Fos/Jun作用强度一致。结论:白藜芦醇低度聚合有利于其中枢镇痛效果提高,这与活性基团和刚性结构增加有关。分子对接方法可用于对白藜芦醇低聚体镇痛活性的虚拟筛选。 Objective: To investigate the interaction of resveratrol oligomer with pain-related gene product Fos/Jun and its analgesic activity in mice. Methods: The interaction of resveratrol oligomers with Fos/Jun mole- cules was simulated by Discovery studio software; the analgesic activity was measured by intracerebroventricular in- jection and hot plate test in mice. Results: Oligomer of resveratrol had stronger interaction with Fos/Jun than mon- omer, the effect increased with polymerizing degree from monomer to trimer, but decreased in tetramer. Resveratrol and its oligomers all had central analgesic effects in mice, and the level was in accordance with the strength of sim- ulated interaction with Fos/Jun. Conclusion : Polymerization of resveratrol in low degree is helpful to its central an- algesic effect, which is attributed to the increase of active groups and rigid structure. Molecular docking method can be used to virtually screen the analgesic activity of resveratrol oligomers.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第1期80-85,共6页 Chinese Journal of New Drugs
基金 国家自然科学基金(81173646)
关键词 白藜芦醇 低聚体 FOS JUN 分子对接 镇痛 resveratrol oligomer Fos/Jun molecular docking analgesic
  • 相关文献

参考文献22

  • 1JANG M, CAI L, UDEANI GO, et al. Cancer chemo-preventive activity of resveratrol, a natural product derived from grapes[J]. Science, 1997, 275(5297): 218-220.
  • 2于晶,任朝阳,苍晶.次生代谢物白藜芦醇研究概述[J].中国农学通报,2005,21(7):104-107. 被引量:22
  • 3CHAN MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the Skin [ J]. Biochem Pharmacol, 2002, 63(2): 99- 104.
  • 4樊慧婷,熊晓云,曹蔚,李小强,邹永,张学景,梅其炳.白藜芦醇烟酸酯与白藜芦醇体内外抗肿瘤作用比较[J].中国新药杂志,2006,15(11):874-878. 被引量:8
  • 5SUBBARAMAIAH K, CHUNG WJ, MICHALUART P, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbolester-treated human mammary epithelial cells [ J ]. J Biol Chem, 1998, 273(34) : 21875 -21882.
  • 6FALCHIL M, BERTELLIL A, GALAZZO R, et al. Central an- talgic activity of resveratrol [ J ]. Archives ltaliennes de Biologie, 2010, 148(4): 389-396.
  • 7GUPTA YK, SHARMA M, BRIYAL S. Antinociceptive effect of trans-resveratrol in rats : involvement of an opioidergic mechanism [J]. Methods Find Exp Clin Pharmacol, 2004, 26(9): 667- 672.
  • 8LINA Y, SHENGLAN W, Yoko Kogure, et al. Modulation of TRP channels by resveratrol and other stilbenoids[ J]. Molecular Pain, 2013, 9: 3.
  • 9许建阳,王发强,刘庆安,宋开源.原癌基因c-fos在痛觉调制的研究进展[J].医学综述,2001,7(10):581-582. 被引量:4
  • 10BILLARD C, IZARD JC, ROMAN V, et al. Comparative anti- proliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (Vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes [ J ]. Leuk Lymphoma, 2002, 43 (10) : 1991 - 2002.

二级参考文献49

共引文献47

同被引文献49

  • 1赵海涛,陈为涛,李万忠.白藜芦醇制备与制剂研究进展[J].亚太传统医药,2009,5(1):113-115. 被引量:6
  • 2康志云,吴祖泽.多羟基二苯乙烯类化合物生物活性及其构效关系研究进展[J].军事医学科学院院刊,2004,28(5):492-494. 被引量:6
  • 3吴晓辉,刘玉玲.微乳作为经皮给药载体的研究进展[J].中国药学杂志,2006,41(22):1681-1685. 被引量:17
  • 4陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 5国家食品药品监督管理局.化学药物刺激性、过敏性和溶血性研究技术指导原则[S].2005-03-14.
  • 6RICHARDS D, ARONSON J. Oxford Handbook of Practical Drug Therapy(牛津临床药物治疗手册)[M].ZHAISD,translation. Beijing: people's medical publishing house, 2006: 690-694.
  • 7ZHANG S Q, TIAN Q P. Preparation of high solubilizable Microemulsion of naproxen and its solubilization mechanism [J]. Int J Pharm, 2012, 426(1-2): 202-210.
  • 8WU H, RAMACHANDRAN C, WEINER N D, et al. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions [J]. Int J Pharm, 2001, 220(1/2): 63-75.
  • 9XU Z. The investigation of naproxen gel-microemulsion transdermal delivery system and its preliminary pharmacodynamics evaluation [D]. Shanxi: Shanxi Medical University, 2010.
  • 10JIN W. The preparation of liposomal gel of nano-silver and its quality evaluation and in vitro antimicrobial activity and safety evaluation [D]. Shanxi: Shanxi Medical University, 2013.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部